India Reports First Suspect Case of Monkeypox

On Sunday, India reported its first 'suspect' case of Monkeypox (Mpox). The Union Health Ministry assured the public there is no cause for undue concern as they monitor the situation closely. A young male patient, who recently travelled from a country experiencing Mpox transmission, has been isolated in a designated hospital after being identified as a suspect case. The patient’s condition remains stable, and samples have been collected for testing to confirm the presence of the Mpox virus.

Government’s Response and Precautions

This development follows the National Centre for Disease Control’s (NCDC) earlier risk assessments, and according to the Union Health Ministry, no additional concern is warranted at this stage. Since the World Health Organization (WHO) declared Mpox a public health emergency of international concern on August 14, 2024, India has been vigilant in managing the risk of transmission. The global alert was first raised in 2022 when Mpox cases were being reported across the world.

In response to the WHO alert, India’s Health Ministry, in collaboration with the NCDC, implemented enhanced surveillance and containment measures. These include monitoring suspected cases at ports of entry, ensuring rapid isolation of patients, and raising community awareness about prevention and hospital infection control strategies.

Key Facts About Mpox

Mpox, caused by the monkeypox virus, belongs to the Orthopoxvirus genus. It is presented in two major clades: clade I (subclades Ia and Ib) and clade II (subclades IIa and IIb). While the 2022 strain was less severe, the recent strain from Africa is more lethal and has raised concerns about transmission through sexual contact.

Symptoms of Mpox:

• Skin rashes or mucosal lesions lasting 2–4 weeks.
• Fever, headaches, muscle aches, low energy, back pain, and swollen lymph nodes.
• Some patients may develop a few lesions, while others may experience hundreds.

Transmission:

Mpox spreads through close contact with infected individuals or contaminated materials, and it can also be transmitted from animals. Pregnant women are at risk of passing the virus to the fetus or newborn during or after birth.

Treatment and Vaccination:

Treatment for Mpox focuses on managing symptoms, including pain, and fever, and preventing secondary infections. Vaccines for Mpox are available and should be considered alongside other public health measures.

While the confirmation of India's first ‘suspect’ case of Mpox may spark concern, the government is taking proactive steps to manage the situation. With rapid isolation, testing, and public health interventions in place, the risk remains controlled, and there is no immediate cause for alarm. Awareness, timely vaccination, and preventive strategies will be essential in curbing the spread of this virus in the future.

Also Read: No Aadhaar Without NRC Application Number: Warns Himanta Sarma